南特炎症性肠病队列 (CELESTE)
肠道慢性炎症疾病队列
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
研究概览
详细说明
The CELESTE cohort will be a prospective cohort of IBD patients followed up at Nantes University Hospital, Jules Verne Clinic (Nantes) and/or Confluent Private Hospital (Nantes). The multicentric nature of the cohort including a tertiary referral center and two secondary care centers is a major asset, enabling the enrolment of a broad spectrum of patients, from those naïve to any immunomodulatory treatment to those refractory to multiple biologic therapies.
It will be associated with a multi-omics biobank with the aim of identifying new cellular and molecular signatures of success of the therapeutic strategy at one year.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Catherine Le Berre, MD
- 电话号码:+33240083152
- 邮箱:catherine.leberre@chu-nantes.fr
学习地点
-
-
-
Nantes、法国
- 招聘中
- CHU de Nantes
-
接触:
- Catherine Le Berre, MD
- 电话号码:+33240083152
- 邮箱:catherine.leberre@chu-nantes.fr
-
Nantes、法国
- 尚未招聘
- Clinique Jules Verne
-
接触:
- Mathurin FLAMANT, MD
-
Nantes、法国
- 尚未招聘
- Hopital Privé du Confluent
-
接触:
- Caroline TRANG, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
IBD patients who are immunomodulator-naive or refractory to one or more lines of immunosuppressive, biotherapy, or small molecule therapy
描述
Inclusion Criteria:
- Patients over 18 years of age;
- Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
- Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
- Patients who have given written consent to participate in the study and to keep biological samples for research purposes
Exclusion Criteria:
- Patients refusing to participate in the cohort;
- Patients with chronic inflammatory bowel disease quiescent at inclusion;
- Patients with a contraindication to general anaesthesia;
- Vulnerable patients (under court protection, curators, guardians);
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Patients
Patients of both sexes, over 18 years of age, with an established diagnosis of IBD (Crohn's desease, ulcerative colitis, unclassified IBD or chronic pouchitis) will be eligible for inclusion in a consultation to schedule surgery or colonoscopy for disease relapse (at diagnosis or prior to initiation of treatment), irrespective of treatment received |
Collection of blood samples and intestinal biopsies during a surgery or colonoscopy for disease relapse |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Proportion of patients who succeed in their therapeutic strategy
大体时间:One year after inclusion
|
Determine the proportion of patients who succeed in their therapeutic strategy at one year |
One year after inclusion
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.